Headline News

 

Final Approval from the USFDA for Zydus’ Chlorthalidone Tablets USP

Posted on May 21, 2019

Peloton Therapeutics to be Acquired by Merck, Bolstering Oncology Pipeline

Posted on May 21, 2019

USFDA Approval for Alembic Pharmaceuticals’ Solifenacin Succinate Tablets, 5 mg and 10 mg.

Posted on May 21, 2019

Novel Approaches to Reimagining Medicine in Cancer and Serious Blood Disorders Demonstrated by Novartis Data at ASCO and EHA

Posted on May 21, 2019

ANDA approval for Glenmark Pharmaceuticals’ Solifenacin Succinate Tablets, 5 mg and 10 mg

Posted on May 21, 2019

Strategy to Deliver Above-Market Growth Outlined by Johnson & Johnson at 2019 Pharmaceutical Business Review

Posted on May 15, 2019

Lupin, Aptissen sign pact to sell Osteoarthritis injection in Canada

Posted on May 14, 2019

Eisai enters into licensing agreement with medac concerning Methotrexate Subcutaneous Injection in Japan

Posted on May 14, 2019

AstraZeneca-Daiichi Sankyo breast cancer drug shows promise

Posted on May 14, 2019

Novartis buys Takeda’s dry eye drug for $3.4 bln

Posted on May 14, 2019

Lupin launches generic seizure drug in US

Posted on May 14, 2019

Zydus Cadila gets USFDA nod for blood pressure lowering drug

Posted on May 14, 2019

AstraZeneca Announce Calquence Phase III ASCEND Trial Met Primary Endpoint at Interim Analysis in Relapsed or Refractory Chronic Lymphocytic Leukaemia and Will Stop Early

Posted on May 07, 2019

Final USFDA Approval Announced by Zydus for Bosentan Tablets & Trientine Hydrochloride Capsules

Posted on May 07, 2019

U.S. Market Launch of Testosterone Gel, 1.62% (20.25 mg/1.25 g pump actuation) Announced by Dr. Reddy’s Laboratories

Posted on May 07, 2019